Skip to content

Efficacy of Hypopressive Exercises Versus Pilates in Women with Abdominal Diastasis in the Postpartum Period: a Randomized Controlled Trial

Efficacy of Hypopressive Exercises Versus Pilates in Women with Abdominal Diastasis in the Postpartum Period: a Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06599541
Acronym
AD-HE-PI
Enrollment
48
Registered
2024-09-19
Start date
2024-10-31
Completion date
2026-01-31
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Diastasis

Keywords

Hypopressive Exercise, Pilates, Abdominal Diastasis, Postpartum

Brief summary

The aim of this study is to compare the effects of two exercise programs in women with abdominal diastasis (AD) during the postpartum. One group will receive hypopressive exercises (HE) and the other will receive pilates exercise. The hypothesis of this study is that the execution of both protocols will offer benefits in the ultrasound values of the AD and in the data collected on the quality of life in the short term and 12 weeks after its completion.

Detailed description

Objective: To compare the efficacy of hypopressive exercises (HE) versus pilates exercise in women with abdominal diastasis (AD) during the postpartum, and to know the effects of each of the exercises independently. Design: Single-blind randomized controlled trial. Setting: Faculty of Physical Therapy of Alcalá de Henares (UAH). Participants: Primiparous women with DA who have vaginal delivery and are in the 3 months postpartum (N=40). Interventions: Participants will be randomly assigned to perform either a HE program focused on freediving work (n=20) or a pilates program focused on exhalation (n=20). The intervention will consist of 3 weekly sessions lasting 30 minutes over 12 weeks, where they will receive a weekly face-to-face and group session and two home sessions. Main outcome measures: The primary outcome will be measurement of the distance between rectus abdominis through ultrasound to be assessed at baseline, immediately after the intervention and 12 weeks later. The secondary outcome measure will correspond to the measurement of quality of life using the SF-36 Health Questionnaire. It will be collected through masked evaluations by 2 physiotherapists at baseline, at the end of the intervention and at 12 weeks.

Interventions

A hypopressive exercise program will be carry out.

BEHAVIORALPilates Exercise

A pilates exercise program will be carry out.

Sponsors

University of Alcala
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Primiparous women over 18 years of age who are within 3 months postpartum. * AD with values >2.5 cm in any of the following reference points: 2 cm supraumbilical or 2 cm infraumbilical. * Vaginal birth.

Exclusion criteria

* Abdominal or umbilical hernia. * Previous abdominal surgery. * Be receiving any other treatment for your AD

Design outcomes

Primary

MeasureTime frameDescription
Distance between rectus abdominis.The measurements will be collected at baseline, immediately after the treatment and 12 weeks after the end of treatment.The distance between both muscle bellies of the rectus abdominis will be measured with an ultrasound (linear probe). It will be measured at two reference points: 2 cm supraumbilical and 2 cm infraumbilical.

Secondary

MeasureTime frameDescription
Quality of lifeThe scale will be passed at baseline, immediately after the treatment and 12 weeks after the end of treatment.The SF-36 consists of a health questionnaire composed of 36 items for the characterization of a person´s health. The total score ranges between 0 and 100 points. A higher score reflects more optimal health.

Countries

Spain

Contacts

Primary ContactAdrián Rosales Torrejón, MSc
adrian.rosales@edu.uah.es+34629488253
Backup ContactAna Serrano Imedio, PhD
ana.serrano@carmasalud.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026